WBWilliam Becker

William Becker

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


William Becker has a total of 27 co-authors. Here are the top co-authors by number of shared publications:

  • Burton E. Becker

    Private Practice, Tucson, Arizona

    10 shared publications
  • Philippe Hujoel

    Department of Oral Health Sciences, School of Dentistry & Department of Public Health, University of Washington, Seattle, Washington

    6 shared publications
  • Lars Sennerby

    Department of Biomaterials, Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

    5 shared publications
  • Moshe Goldstein

    Director, Postgraduate Periodontology, Faculty of Dental Medicine, Hadassah‐Hebrew University Medical Center, Jerusalem, Israel

    4 shared publications
  • Ami Smidt

    Director, The Hebrew University‐Hadassah, Head, the Center for Graduate Studies in Prosthodontics, Jerusalem, Israel [Correction added to online publication 24 January 2011

    2 shared publications
  • Peter Wohrle

    Private Practice Limited to Periodontics and Dental Implants, Newport Beach, CA, USA

    2 shared publications

Latest Publications

  • Bone loss around oral and orthopedic implants: An immunologically based condition

    by Tomas Albrektsson, William Becker, Pierluigi Coli, Torsten Jemt, Johan Mölne, Lars Sennerby

    Background: Marginal bone resorption has by some been identified as a “disease” whereas in reality it generally represents a condition.Purpose: The present article is a comparison between oral and orthopedic implants, as previously preferred comparisons between oral implants and teeth seem meaningless.Materials and Methods: The article is a narrative review on reasons for marginal bone loss.Results and Conclusions: The pathology of an oral implant is as little related to a tooth as is pathology of a hip arthroplasty to a normally functioning, pristine hip joint. Oral as well as orthopedic implants are recognized as foreign bodies by the immune system and bone is formed, either in contact or distance osteogenesis, to shield off the foreign materials from remaining tissues. A mild immune reaction coupled to a chronic state of inflammation around the implant serve to protect implants from bacterial attacks. Having said this, an overreaction of the immune system may lead to clinical problems. Marginal bone loss around oral and orthopedic implants is generally not dependent on disease, but represents an immunologically driven rejection mechanism that, if continuous, will threaten implant survival. The immune system may be activated by various combined patient and clinical factors or, if rarely, by microbes. However, the great majority of cases with marginal bone loss represents a temporary immune overreaction only and will not lead to implant failure due to various defense mechanisms.


  • Open Access

    Has implant dentistry lost its direction??

    by William Becker, Leonard Tibbetts

  • Resonance frequency analysis: Comparing two clinical instruments

    by William Becker, Philippe Hujoel, Burton E. Becker

    Background: Numerous studies indicate implants placed immediately after extraction or with minimally invasive procedures have excellent long‐term success and survival rates. There is general agreement that implants must be stable after implant placement. This study evaluated implant stability changes from the time of implant placement to second stage (prior to restoration). Resonance frequency analysis (RFA) was determined for two commercially available units (Osstell, Osstell USA, Columbia, MD and Penguin, Penguin Integration Diagnostics, Sweden). The unit of measurement was the implant stability quotient (ISQ).Materials and Methods: Prior to treatment patients were given medical and dental evaluations. Periapical and panogram radiographs were taken Computerized tomography images were taken for sites where adequate bone volume or quality were uncertain. Thirty patients were enrolled in this study (13 females, 17 males, mean age 73.4 years, (maximum age 90, minimum 47 year total of 38 implants were placed. One implant was lost. Computerized implant planning (Nobel Clinician) Nobel Biocar United States (Nobel Biocare, Yorba Linda, CA) was performed for all patients. Implants were placed utilizing a surgical guide. Using Resonance Frequency anal this study compared two RFA systems for determining implant stability (ISQ; Osstell and Penguin). Measurement pegs were screwed into the implants, and RFA measurements were taken at mesial, distal, lingual, and buccal implant surfaces. Stability measurements were taken at implant placement and at second stage. Clinical data and RFA measurements were recorded on data sheets. The average interval between first and second stages was 144.1 days (range 21.3)Results: Average interval between implant placement and second stage was 141.1 days. One implant was lost prior to second stage. The results are based on 30 patients with 38 implants. At second stage, the RFA measures were slightly higher than first stage with a mean increase of 1.15, SE = 0.3, P–.067. The Penguin RFA values were marginally higher than Osstell (mean increase 1.10, SE = 0.64, P < .08).Conclusions: RFA values between implant placement and second stage differed slightly between implant placement and second stage (P < 0.10). These differences were not clinically or statistically significant. At second stage, Penguin RFA values were slightly higher when compared with the Osstell device (P < 0.67). Bone quality appears to be an important factor when determining RFA readings. Type I bone had significantly higher readings when compared with other less dense bone types (P < .029) Resonance frequency evaluation data were similar for both instruments, indicating their reliability in determining implant stability. Neither instrument predicted implant failure. While subjective, Penguin was less cumbersome to utilize and the window revealing the readings was very easier to read. Further, the pegs are magnetized making insertion easy.


  • Dental Implants in an Aged Population: Evaluation of Periodontal Health, Bone Loss, Implant Survival, and Quality of Life

    by William Becker, Philippe Hujoel, Burton E. Becker, Peter Wohrle

    Purpose: To evaluate aged partially and fully edentulous patients who received dental implants and were maintained over time. Further, to determine how the partially and edentulous ageing populations (65 and above) with dental implants maintain bone levels, proper oral hygiene, and perceive benefits of dental implants.Materials and Methods: Since 1995, patients receiving dental implants have been prospectively entered into an Access‐based computerized program (Triton Tacking System). Patient demographics (age, sex), bone quality, quantity, implant location, and type of surgery have been continuously entered into the database. The database was queried for patients receiving implants (first stage) between 66 and 93 years of age. Thirty‐one patients were within this age group. Twenty‐five patients returned to the clinic for periodontal and dental implant evaluation. The Periodontal Index was used to evaluate selected teeth in terms of probing depth, bleeding on probing, plaque accumulation, and mobility. Using NIH I mage J, radiographs taken at second stage and last examination were measured for changes in interproximal bone levels. Once identified, each patient anomalously filled out an abbreviated quality of health life form. Due to small sample size, descriptive statistics were used to compare clinical findings.Results: Fifteen males ranging from 78 to 84 (mean age 84 years) years and 16 females from 66 to 93 (mean age 83 years) (age range 66–93) were contacted by phone or mail and asked to return to our office for a re‐examination. For this group, the first dental implants were placed in 1996 (n = initial two implants) and continuously recorded through 2013 (n = last seven implants). Thirty‐one patients received a total of 84 implants. Two patients were edentulous, and the remaining were partially edentulous. Four implants were lost. Between implant placement and 6‐ to 7‐year interval, 13 patients with 40 implants had a cumulative survival rate of 94.6%. Of the original group (n = 33), three were deceased, two were in nursing homes, and three could not be located.Conclusions: Aged patients receiving dental implants had excellent implant survival rates, low periodontal disease index scores with minimal changes in interproximal bone levels. Results from this study indicate that patients with advanced age, in reasonably good health, have excellent implant survival rates, excellent quality of life scores, and can be maintained in good oral health.


  • Survival Rates and Bone Level Changes around Porous Oxide‐Coated Implants (TiUnite™)

    by William Becker, Philippe Hujoel, Burton E. Becker, Peter Wohrle

    Purpose: This prospective study evaluated implant survival rates and crestal bone changes for porous oxide‐coated (TiUnite, Nobel Biocare AB, Gothenburg, Sweden), parallel‐walled implants.Materials and Methods: All patients receiving TiUnite (porous oxide‐surfaced implants [POS]) implants were entered into a database (Triton Tracking System) starting February 1999. Survival rates were calculated from the date of implant placement and related to surgical method of placement (two‐stage buried, flapless, immediate placement, immediate placement flapless, one stage), bone quality, and implant characteristics. Failed and nonfailed implants were compared with respect to changes in mean proximal bone levels and the presence of radiolucent areas around the implant apex (shadows).Results: Four hundred nine patients received 817 porous oxide‐coated implants, of which 38 failed. Using the last office visit as the censoring date, the cumulative survival date was 93%. The failure rate was independent of bone quality or quantity; implant diameter or length; and surgical method. For the 102 surviving implants, there was no significant change in the average crestal bone loss (+0.13 mm with a standard error, 0.17). For the 17 failing implants, the average crestal bone loss was −4.14 mm (standard error, 0.55). This difference between bone levels of failing and nonfailing implants was highly significant (p < .0001). There was no difference in the prevalence of radiographic shadows around failing and nonfailing implants at time of placement (p < .16).Conclusion: Results from this prospective clinical study indicate that 7% of TiUnite surfaced implants failed for unknown reasons. Failing implants were characterized by significant bone loss but not by the presence of shadows.


  • A Novel Method for Creating an Optimal Emergence Profile Adjacent to Dental Implants

    by William Becker, John Doerr, Burton E. Becker

    In order to establish an optimal esthetic implant result, creation of an optimal emergence profile is necessary. The purpose of this clinical report is to describe a new method for creating an emergence profile starting at the time of immediate implant placement. Clinical steps for creating the emergence profile are described from the time of implant placement to restoration. Prefabricated abutments that can be modified and used as healing abutments or for provisional restorations offer clinicians the opportunity to create emergence profiles during the healing phase after immediate implant treatment. This procedure eliminates the need for creation of an arbitrary emergence profile in the dental laboratory and eliminates the need for a surgical procedure prior to impression making.


  • Prospective Clinical Trial Evaluating a New Implant System for Implant Survival, Implant Stability and Radiographic Bone Changes

    by William Becker, Burton E. Becker, Philippe Hujoel, Zakaria Abu Ras, Moshe Goldstein, Ami Smidt

    There are a few prospective studies reporting on new implant systems. When a new implant is brought to market, prospective trials should be carried out to determine the predictability of that system. This prospective study evaluates implant survival, Resonance Frequency Analysis (RFA), and crestal bone level changes for a new implant system (Neoss System, Bimodal surface, Neoss Ltd, Harrogate, UK). Seventy-six patients, 38 females (age ranging from 23 to 57 years) and 38 males (ranging in age from 17 to 85 years) received 100 Neoss implants. Patients were consecutively enrolled in the study if they were missing one or more teeth in either arch, or a single tooth was scheduled for removal and immediate implant replacement. Evaluated implants were 4, 4.5, or 5 mm wide and were 7, 9, 11, 13, or 15 mm long. A one-stage approach was followed. At first stage and prior to healing abutment placement RFA measurements were taken. Measurements were retaken at second stage. Fifty-one implants were placed for restoration of single missing teeth and 49 were for short span implant bridges. The cumulative survival rate at 1- to 2-year interval was 93%. Average initial RFA measurement for all implants was 72.06, while the average final score was 72.58. These changes were not statistically significant. Changes in RFA scores for maxillary implants were insignificant. Forty-two paired mandibular RFA measurements were evaluated. Initial and final mean mandibular RAF measurements were 73.65 (SD 9.203) and 77.186 (SD 6.177), respectively. These changes were statistically significant (p = .02). Sixty-four paired radiographs were available for evaluation. Between examinations, there was an average -0.6 mm of bone loss, which was statistically significant (p = .03). On average, 4.0-mm-wide implants lost 0.1 mm of bone when compared with 5-mm-wide implants. These differences were insignificant (p = .86). Bone loss was adjusted for implant length, and tooth position and there were small, but clinically insignificant changes. Five-millimeter-wide implants lose 0.2 mm more than 4.0-mm-wide implants (p = .7). Maxillary incisors lose the least amount of bone 0.152 (p = .33). The implants tested in this study had initially high RAF readings, indicating good primary stability. RFA readings for implants placed in the mandible improved from baseline and the changes were statistically significant. Marginal bone levels revealed clinically insignificant bone loss from implant installation to second stage. Loss of seven implants with initially high RFA readings is surprising.


  • Minimally Invasive Treatment for Papillae Deficiencies in the Esthetic Zone: A Pilot Study

    by William Becker, Ildor Gabitov, Misha Stepanov, John Kois, Ami Smidt, Burton E. Becker

    Background: The presence of papillary deficiencies adjacent to dental implants or teeth presents an esthetic concern for the dental team and patients.Purpose: The aim of this pilot project is to evaluate a new method for reducing or eliminating small papillary deficiencies. The use of a commercially available gel was evaluated as a possible method for enhancing deficient papillae.Materials and Methods: Eleven patients, seven females and four males, with an average age of 55.8 years (ranging from 25 to 75 years) with 14 treated sites are included in this pilot study. Patients had a minimum of one papillary deficiency in the esthetic zone. Prior to treatment photographs were either taken at a 1:1 ratio or converted to a 1:1 ratio using a commercially available program. A standardization photographic device was not used. After administration of a local anesthetic, a 23‐gauge needle was used to inject less than 0.2 mL of a commercially available and Food and Drug Administration‐approved gel of hyaluronic acid 2–3 mm apical to the coronal tip of the involved papillae. Patients were seen every three weeks and treatment was repeated up to three times. Patients were followed from 6 to 25 months after initial gel application. A computer program measured changes in pixels between initial and final treatments. A formula was derived to determine percentage change in the negative space between initial and final examinations.Results: Each site was individually evaluated. Three implant sites and one site adjacent to a tooth had 100% improvement between treatment examinations. Seven sites improved from 94 to 97%, three sites improved from 76 to 88%, and one site adjacent to an implant had 57% improvement.Conclusion: Results from this pilot study are encouraging and present evidence that small papillary deficiencies between implants and teeth can be enhanced by injection of a hyaluronic gel. Improvements were maintained for a range of 6 to 25 months.


  • Minimally Invasive Flapless Implant Placement: Follow‐Up Results From a Multicenter Study

    by William Becker, Moshe Goldstein, Burton E. Becker, Lars Sennerby, Dean Kois, Philippe Hujoel

    Background: The placement of implants using a minimally invasive flapless approach has the potential to reduce operative bleeding and postoperative discomfort and minimize crestal bone loss. This article presents follow‐up data on a prospective clinical study of implants placed using a flapless procedure.Methods: The original study reported on 57 patients (33 female patients with an age range of 24 to 86 years; 24 male patients with an age range of 27 to 81 years) recruited from three clinical centers (Tucson, Arizona; Gothenburg, Sweden; and Tel Aviv, Israel) who received 79 implants. After an average of 3 years and 8 months, the patients were contacted and invited to return to their respective clinics for reexamination. Thirty‐seven patients with 52 implants returned for a follow‐up examination; the remaining 20 patients (27 implants) were not available for reexamination and were considered study drop‐outs.Results: The cumulative survival rate at the 3‐ to 4‐year follow‐up examination remains at 98.7%, reflecting the loss of one implant. The mean probing depth at abutment connection was 2.2 mm, as reported in the initial study (examination 2 at ∼2 years postplacement); it was 2.4 mm at the 3‐ to 4‐year second follow‐up examination. This change was not clinically or statistically significant. Bleeding score changes also were not significant between the two intervals. The average crestal bone level was −0.7 mm at examination 2 and −0.8 mm at examination 3, a change that approached significance (P Conclusions: Minimally invasive flapless surgery offers patients the possibility of high implant predictability with clinically insignificant crestal bone loss for up to 4 years. Proper diagnosis and treatment planning are key factors in achieving predictable outcomes.